Macrophage protease-activated receptor 2 regulates fetal liver erythropoiesis in mice
Open Access
- 24 November 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (22) , 5810-5824
Abstract
Deficiencies in many coagulation factors and protease-activated receptors (PARs) affect embryonic development. We describe a defect in definitive erythropoiesis in PAR2-deficient mice. Embryonic PAR2 deficiency increases embryonic death associated with variably severe anemia in comparison with PAR2-expressing embryos. PAR2-deficient fetal livers display reduced macrophage densities, erythroblastic island areas, and messenger RNA expression levels of markers for erythropoiesis and macrophages. Coagulation factor synthesis in the liver coincides with expanding fetal liver hematopoiesis during midgestation, and embryonic factor VII (FVII) deficiency impairs liver macrophage development. Cleavage-insensitive PAR2-mutant mice recapitulate the hematopoiesis defect of PAR2-deficient embryos, and macrophage-expressed PAR2 directly supports erythroblastic island function and the differentiation of red blood cells in the fetal liver. Conditional deletion of PAR2 in macrophages impairs erythropoiesis, as well as increases inflammatory stress, as evidenced by upregulation of interferon-regulated hepcidin antimicrobial peptide. In contrast, postnatal macrophage PAR2 deficiency does not have any effect on steady-state Kupffer cells, bone marrow macrophage numbers, or erythropoiesis, but erythropoiesis in macrophages from PAR2-deficient mice is impaired following hemolysis. These data identify a novel function for macrophage PAR2 signaling in adapting to rapid increases in blood demand during gestational development and postnatal erythropoiesis under stress conditions.Keywords
This publication has 67 references indexed in Scilit:
- Pharmacological targeting of the thrombomodulin–activated protein C pathway mitigates radiation toxicityNature Medicine, 2012
- Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal HyperplasiaArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Tissue factor–protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammationNature Medicine, 2011
- The Endothelial Protein C Receptor Supports Tissue Factor Ternary Coagulation Initiation Complex Signaling through Protease-activated ReceptorsJournal of Biological Chemistry, 2011
- Local Protease Signaling Contributes to Neural Tube Closure in the Mouse EmbryoDevelopmental Cell, 2010
- Protease‐activated receptor 2 signalling promotes dendritic cell antigen transport and T‐cell activationin vivoImmunology, 2009
- Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivoMucosal Immunology, 2009
- Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXRImmunity, 2009
- IFN regulatory factor (IRF) 3/7‐dependent and ‐independent gene induction by mammalian DNA that escapes degradationEuropean Journal of Immunology, 2008
- 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damageNature Immunology, 2007